6039 logo

Japan Animal Referral Medical Center Co., Ltd. Stock Price

TSE:6039 Community·JP¥16.3b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

6039 Share Price Performance

JP¥1,262.00
743.20 (143.25%)
JP¥1,262.00
743.20 (143.25%)
Price JP¥1,262.00

6039 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Solid track record with adequate balance sheet.

2 Risks
2 Rewards

Japan Animal Referral Medical Center Co., Ltd. Key Details

JP¥6.0b

Revenue

JP¥3.7b

Cost of Revenue

JP¥2.3b

Gross Profit

JP¥1.5b

Other Expenses

JP¥787.0m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
60.90
38.85%
13.13%
70.9%
View Full Analysis

About 6039

Founded
2005
Employees
294
CEO
Hidehiro Hirao
WebsiteView website
jarmec.co.jp

Japan Animal Referral Medical Center Co., Ltd., together with its subsidiaries, owns and operates animal hospitals that provide advanced medical treatment for dogs and cats in Japan. The company’s medical centers consist of cardiology, respiratory, urology, gastroenterology, oncology, neurology, orthopedics, ophthalmology, radiology and imaging, and anesthesiology departments. It also provides professional training services for veterinarian training and education for advanced medical treatments; and conducts research and development projects, including genetic testing, immunotherapy, and regenerative medicine. Japan Animal Referral Medical Center Co., Ltd. was incorporated in 2005 and is headquartered in Kawasaki, Japan.

Recent 6039 News & Updates

Recent updates

No updates